OncoBay Clinical Taps Montrium’s Quality Connect to Power Growing Quality & Regulatory Teams

OncoBay Clinical Selects Quality Connect to Simplify Compliance

Montreal, CA and Tampa, FL, USA – May X, 2021
Montrium, a leader in cloud-based software solutions for life sciences, today announced that OncoBay Clinical, Inc., a full-service boutique contract research organization (CRO) specializing in the simplification of complex oncology programs, has adopted Quality Connect to centralize the Quality operations of their fast-growing organization.
With a rapidly growing Quality and Regulatory team, OncoBay Clinical launched a technology evaluation and selection initiative with the goal of simplifying quality operations and training compliance. The company now benefits from a robust and powerful electronic Quality Management System in Quality Connect, allowing them to simply tackle their quality challenges head-on while driving compliance.
“OncoBay selected Montrium as our QA technology partner of choice,” said Krystyna Kowalczyk, President and Chief Executive Officer of OncoBay Clinical. “Quality Connect further enhances the OncoBay foundation of integrating all systems and driving centralized quality assessments through all aspects of the organization. With Quality Connect, we integrate quality management, training, and process assessment into our centralized information-driven operational hub.”
“Quality Connect plays a vital role in minimizing risk while providing real-time, proactive insights into OncoBay operations,” said Lisa Zimmerman, Vice President of OncoBay Regulatory and Quality Assurance. “Unlike many of the platforms we evaluated, Montrium Quality Connect represents a turn-key solution with the features we were looking for yet offered at a competitive price point.”
“We are thrilled to be working with OncoBay Clinical and helping them to automate the lifecycle of their controlled documents, ultimately allowing them to spend more time providing the highest quality CRO services to their sponsor partners. This partnership represents the enormous transformative power that cloud-based solutions have to streamline Quality operations for fast-growing, agile teams,” said Oliver Pearce, Director of Commercialization at Montrium.

Additional Information
• For more information, please visit: www.montrium.com and https://www.oncobay.com/ .com
• To learn more about how Quality Connect can improve your clinical trial operations, please visit https://www.montrium.com/quality-management/
• Connect with Montrium and OncoBay Clinical on LinkedIn.
About Montrium
Founded in 2005, Montrium is one of the leading providers of cloud-based collaborative content management software to the life sciences industry. With experience in serving over 200 life science customers in 20+ countries, Montrium is committed to delivering an unparalleled customer experience to emerging growth organizations as a true technology partner. Montrium has offices in Montreal, Canada, and Brussels, Belgium.
About OncoBay Clinical
OncoBay Clinical is a boutique CRO specializing in immuno-oncology/cell therapy, offering full-service custom curated CRO solutions for global pharmaceutical and biotech companies looking to advance their immuno-oncology product or device. As a wholly owned, for-profit subsidiary of Moffitt Cancer Center, OncoBay embeds scientific expertise, operational excellence, and integrated cell manufacturing capabilities providing true end-to-end control. Built on years of IO and cell therapy expertise, a streamlined technology framework, a highly trained site network, and a dedicated team of experienced professionals, OncoBay is committed to operational excellence from start to finish. For more information, visit Oncobay.com and follow us on Facebook, Twitter, and LinkedIn.
Media Contacts:

OncoBay Clinical
Krystyna Kowalczyk
President and CEO

Shima Healey
Marketing Manager, Montrium
T: +1 514 .223. 9153 ext. 283 (North America)
T: +32.2.808.30.08 ext. 283 (Europe)

Take Advantage of OncoBay’s Innovative Approach


Submit a Request for Proposal

Submit Proposal

OncoBay is now Kapadi


Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.


Visit Kapadi.com


This window will auto-close in 15 seconds.

This will close in 7 seconds